Becoming more clinically efficient with digital tech.
View as Webpage
Introducing IBM Study Advance at SCOPE Summit 2020. Learn more >>
 
 
 
Subscribe
 
 
 
February 3, 2020
 
OneMedical Apps
 
 

Tech-enabled primary care business 1Life Healthcare — better known by its brand name, One Medical — hit the public market Friday after announcing the sale of 17.5 million shares at $14 each. This pricing alongside the roughly 122 million outstanding shares disclosed in the company’s S-1 would put One Medical’s valuation at just over $1.7 billion.

And although it’s only been on the market for a couple of trading days, investors appear to be interested in One Medical’s business. As of Monday February 3, the company’s stock is fluctuating between $22 and $24.50.

“Going public further affirms our human-centered, technology-powered model and our mission to transform health care at scale,” CEO, President and Chair of One Medical Amir Dan Rubin said in a statement. “Publicly raising funds will allow us to widen our reach and impact. It also creates an opportunity for a broader group of investors to participate in our vision to delight millions of members with better health and better care, while lowering costs.”

One Medical is defined by its hybrid model of in-person and online primary care. Catering to employer programs as well as individuals, the company provides its members with 24-7 access to virtual health services, accommodates members regardless of which brick-and-mortar clinic they attend and will refer patients for specialty care as necessary.

According to the SEC documents filed earlier this year, One Medical has 72 primary care offices spread across the country. Individual patients can join the service for a yearly rate of $199 on top of their insurance, or employers can purchase the service for their members. In the filing, the company boasts of having around 397,000 members and 6,000 enterprise clients. 

Founded in 2007, the Californian company has roughly $532.1 million in funding, according to Crunchbase. The most recent raise consisteted of $350 million from The Carlyle Group

WHY IT MATTERS

2019 marked the return of the health tech IPO. Major names like chronic care management company Livongo, health data analytics company Health Catalyst and workflow management company Phreesia each went through the ringer and came out the other side with varying levels of success.

However, not too long after came WeWork’s disastrous IPO filing and subsequent withdrawal. Although the coworking startup’s business hardly falls within the realm of healthcare, enough investors were rattled to kick off a new wave of debate around the real and perceived value of tech and tech-adjacent startups.

Although it came in on the slightly lower side of its anticipated range, One Medical’s debut and sustained success will act as a barometer for confidence in the public digital health marketplace.

“Once you go public you are in it for the long haul,” Sean Day, a research analyst at Rock Health, told MobiHealthNews in an October interview discussing the 2019 IPOs. “I think the interesting questions are around how will public investors value these companies. At the moment a company like Livongo, they’re not a pure software company, they’re not a pure healthcare company. They’re an interesting new blend of scaling human providers and coaches to deliver care with technology.”

MARKET SNAPSHOT

Healthcare is continuing to see the growth and emergence of hybrid telehealth and brick-and-mortar clinics.

Take for instance Emilio Health, a pediatric behavioral health startup that recently announced new brick-and-mortar clinics with specialty services including occupational therapy and behavioral specialists. The startup is also incorporating a digital platform, which can be used to help track progress, schedule appointments and access teletherapy. 

Other examples include Carbon Health, which also delivers primary care in the Bay Area, and Kindbody, which brings a similar approach to women’s health.

 
VivaLNK
 
 

Photo Credit: Labor Watch News

VivaLNK, a Santa Clara, California-based connected health startup, recently announced that Shanghai Public Health Clinical Center (SPHCC) is using the startup’s continuous temperature sensor to combat the spread of coronavirus in China. Modeled after the previous SARS outbreak in 2003, SPHCC contains special wards designed to limit cross infection and to provide more efficient treatments.

SPHCC is designated as the primary treatment center in Shanghai, and confirmed patients from area hospitals are also sent to the SPHCC for quarantine and treatment.

WHY IT MATTERS

On Jan. 30, the World Health Organization declared the coronavirus a Public Health Emergency of International Concern. According to a BBC News report, the death toll from the outbreak in China has reached 170 and a confirmed case in Tibet means the virus has reached every region in mainland China. 

A key challenge in combating contagious diseases is limiting the spread of the virus within a hospital. Cross infection from patient-to-patient and patient-to-caregiver can be a major problem. While quarantining patients may limit patient-to-patient contact, contact between caregivers and patients can also be avoided with technology.

HOW IT WORKS

Working with VivaLNK solution partner Yijing Health, the temperature sensor is applied directly onto the patient and allows for continuous, real-time monitoring of changes in body temperature. The data is then sent electronically from the patient to a remote observation dashboard at the nursing station, which allows nurses/healthcare staff to monitor them easily and safely. Instead of physically checking the patient's temperature every few hours with a mercury thermometer, temperatures can be monitored remotely and automatically, thereby limiting patient-to-caregiver contact.

SPHCC also plans to deploy other VivaLNK sensors to monitor such vitals as heart rate and respiratory rate. The VivaLNK solution has been deployed in four other hospitals in various locations throughout China.

THE LARGER TREND

Singapore-based Veredus Laboratories is working on the development of the VereCoV detection kit, a portable Lab-on-Chip application capable of detecting Wuhan Coronavirus in a single test, MobiHealthNews reported. The detection kit is slated to be commercially available by Feb. 1 this year.

A STAT article reported that AI is becoming a useful tool in efforts to monitor and respond to global outbreaks such as the coronavirus. Millions of posts about coronavirus on social media and news sites are allowing algorithms to generate near-real-time information for public health officials tracking its spread.

ON THE RECORD

"The world will never be rid of diseases, but more effective methods of prevention and treatment can be achieved through technological advances," said Jiang Li, CEO of VivaLNK, in a statement.

 
 
ADVERTISEMENT
IBM
 
 
 
Legacy provides customers with a personalized digital report of their reproductive health within 24 hours of receiving a sample.

Keep Reading >>
 
 
 
The new system lets clinicians share or capture videos and images from the OR.

Keep Reading >>
 
 
HIMSS20 Preview
 
During the opening days of HIMSS20, attendees will unpack key topics that play a pivotal role in the evolution of healthcare and how it cares for patients. With programs focused on education, networking and problem solving, attendees of these forums and specialty programs will focus on the top health information and technology trends shaping the future of healthcare.
 
 
 
Report predicts growth will be driven by provider operations and alternative care companies.

Keep Reading >>
 
 
 
It might just be a matter of time until a phishing attempt finds its mark, meaning that the best strategy for healthcare organizations is to understand their attackers and prepare for the worst, says Healthmap Solutions CISO Kathleen Mullin.

Keep Reading >>
 
 
Call for Proposals
 
This is a peer-to-peer event and we are particularly interested in how hospitals and health systems have implemented machine learning and AI to improve care, control costs, and drive operational efficiencies – in short, to provide better, more patient-centric care, achieve strategic goals, and create a more sustainable organization.
 
 
 
Dr. Ramadan AlBlooshi, Dubai Healthcare City Authority in the UAE, says for "telewellness" to have a major impact, telemedicine's treatment, prescription and follow-up process needs to improve.

Watch Now >>
 
 
 
Yauheni Solad, medical director of digital health at Yale New Haven Health, says creating a robust API infrastructure - a living system where everything is connected so data is available for decision-making – is the current goal.

Watch Now >>
 
 
By HIMSS Insights
 
Connected Care is about patients moving smoothly from their home through the continuum of care and back, depending on their medical needs and facilitated by data that is immediately available wherever it's needed. Making data available is about interoperability, but in a broad sense. IT tools have to be able to communicate, and so do the people involved. Healthcare made some progress recently with technical standards, but are we improving human-to-human interoperability too?

Download the ebook now >>
 
 
ADVERTISEMENT
HIMSS20
 
ASSESSING EMERGING TECHNOLOGIES
 
What you need to know
 
Today, industry players are zeroing in on the best ways to assess these new technologies coming into the market. But each stakeholder has a different priority — which means a different way of evaluating these tools. This month MobiHealthNews will be taking a closer look at how digital tools are validated and assessed by health systems, payers and investors.
 
 
 
 
 
2 Monument Sq., Ste 400 Portland, ME 04101
 
 
.